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My senior honors project has consisted of two components: 
a research paper and practical experience by way of observation 
and communication with wellness experts. The library work that 
ultimately went into the research paper has been done to increase 
my knowledge about a topic in the health-related field. The 
practical experience has come about from observing presentations, 
lectures, and the actual functioning of a company's wellness 
resource center. 
I chose to focus my area of research on hypertension and the 
implications it can have on businesses. My study of this topic 
has increased my understanding of a health-related concern which 
I knew very little about. 
I spent time at Blue Cross Blue Shield, Indianapolis, in 
the Wellness Resource Center. While at Blue Cross Blue Shield, 
I had the opportunity to talk with several staff members and 
learn more about what various companies are doing to promote 
wellness in the workplace. This experience has given me new 
insight into how wellness ,is a relevant area of concern for 
businesses today. 
Therefore, the following work is divided into two (2) 
separate sections. 
hypertension, and 
The first section is the research paper on 
the second section is a summary of my 
activities with Blue Cross Blue Shield. The two sections are 
separate from each other in content, but both components are part 
of my senior honors project. 
An Evaluation of the Economics of Hypertension: 
How Can We Control the Problem and Its Costs? 
Part A 
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INTRODUCTION 
Facts and Concerns 
Hypertension, an increase in 
arteries and arterioles, is the 
blood pressure within 
most prevalent of all 
cardiovascular diseases. Because it does not make a person 
feel ill and rarely causeS symptoms, many people who have 
high blood pressure are not even aware that they fall 
outside the normal blood pressure range. In a 1972 survey 
only 51% of persons with hypertension were aware of their 
condition. The statistics have improved as awareness has 
increased, and in 1984 85% of all hypertensives were aware 
they had high blood pressure. However, education and 
aggressive treatment programs for hypertension are still a 
necessity (Charles Lenfant, 1987, p. 2709). Basically the 
only reliable way to diagnose hypertension is to have your 
doctor take your blood pressure using an instrument called a 
sphygmomanometer. People often learn they have raised blood 
pressure when they visit the doctor about something else. 
The fact that many people do not know they are at risk for 
high blood pressure is a cause for concern among health 
educators, physicians, employers, and society in general. 
Information and education 
interchangeably with high 
about 
blood 
hypertension 
pressure) , 
(used 
must be 
emphasized so people will become more aware of the risks, 
and what they can do on an individual basis to control these 
risks. 
The United States Public Health Service defines 
hypertension as a condition in HŸUÙȘUĚ the flow of blood 
consistently exerts too much pressure against the walls of 
the blood vessels. Over a period of years, excessive 
pressure can damage the heart and blood vessels and result 
in premature aging of the arteries (Sharon Johnson, 1985, p. 
168). High blood pressure increases the risk of stroke, 
heart failure, sudden death, heart attack, peripheral blood 
vessel disease, and kidney failure. Only recently it has 
been determined that 30.8 million American workers were 
afflicted with the disease, which contributes directly or 
indirectly to about 1 million deaths per year (American 
Heart Association, 1986, p. 41) • The American Heart 
Association (AHA) now estimates that one out of every five 
individuals in the United States has hypertension, and that 
two out of three aged 65 or over have the disease. As the 
number of elderly persons increases, high blood pressure 
will become a mOFe significant public health problem. 
In 1980 three principal areas of concern were expressed 
by the National Institute of Health (NIH) regarding 
hypertension control. These include: 1.) increasing the 
public's knowledge of high blood pressure, 2.) encouraging 
the adoption of behaviors conducive to high blood pressure 
control, and 3.) implementing systems designed to improve 
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control methods (Lenfant, p. 2709). The Institute has 
conducted various surveys since 1980, and there is evidence 
of progress 
of concern. 
in meeting the goals that relate to these areas 
ŸŬŲŤĚ respondents than ever seem to understand 
the consequences of high blood pressure and are taking steps 
to reduce potential risks. The nation's hypertension 
objectives can only be met if both public and private 
organizations continue to educate about hypertension, and 
if individuals make an effort to control the disease. 
Definitions 
Before discussing further issues, it is necessary to 
define several terms that will be used throughout the 
following pages. 
Systolic pressure. The pressure on the blood vessels 
when the heart muscle contracts (pumping measure); the level 
to which the arterial pressure rises with each contraction. 
Diastolic pressure. The pressure in the blood vessels 
when the heart muscle relaxes (resting measure); the level 
of arterial pressure in the relaxation phase. 
Arterial blood pressure. The force which is exerted by 
the blood against the inner walls of the arteries; expressed 
in centimeters or millimeters of mercury (em or mm Hg). 
Normotensive. The normal accepted range for arterial 
blood pressure is 90 - 140 mm Hg for the systolic pressure 
and 60 - 90 mm Hg for the diastolic pressure. 
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Borderline hypertensive. The range where systolic 
pressure lies between 140 and 160 mm Hg and the diastolic 
pressure between 90 and 95 mm Hg. This corresponds to the 
upper limits of the normal statistical range. 
Hypertensive. Arterial blood pressure readings where 
systolic pressure is above 160 mm Hg and/or when diastolic 
pressure is above 95 mm Hg. 
A. essential (primary) hypertension. The disease 
process where no precise cause can be detected; 95% of all 
cases. 
B. secondary hypertension. The disease process 
where precise causes can be identified; 5% of all cases. 
Aggregate cost figures. Total costs (direct and 
indirect) to society. It is difficult to break the total 
down into various groupings; 
be estimated. 
therefore, these figures must 
Cost-effectiveness (of a health care practice). The 
net cost in dollars per unit of health benefits gained. The 
lower the ratio of costs to effectiveness, the more cost-
effective a givep health program is. 
Opportunity costs. 
use of resources. 
The value of the best alternative 
Yield (in terms of health). The extent to which risk 
in the entire workforce is lowered. 
available reports of intervention. 
4 
It is assessed from 
Compliance. The extent to which a person's behavior 
(keeping appointments, taking medication, executing life-
style changes) coincides with medical advice. 
Testing procedure. A fabric covered cuff is wrapped 
around the arm just above the elbow, and inflated until 
blood stops flowing through the artery in the arm. Air is 
then gradually released to reach the relaxation rate. To be 
really accurate, the physician should take the blood 
pressure reading twice in one visit. 
Factors 
The previously mentioned definitions are not "perfect" 
definitions. With regard to hypertension there are other 
factors that must be taken into consideration before one can 
classify a person as hypertensive or otherwise. First, 
genetic and social factors need to be examined. Age plays a 
part because arterial pressure is not stable throughout 
life. As people age blood pressure tends to rise 
progressively; therefore, what is normal for a 65 year old 
person might be considered too high for a younger person. 
Because of this "natural tendency, each individual should 
discuss his/her situation with a doctor to decide what 
actions should be taken to control blood pressure (Michael 
O'Donnell, 1986, p. 96). Gender must also be taken into 
account when judging the normality of arterial pressure. 
Women normally have lower arterial pressures than men of 
similar age; therefore, with all other things being equal a 
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woman has less a chance of falling into the hypertensive 
range. 
Hypertension 
specifically it 
is 
is 
a disease unique to 
related to industrial 
humans; more 
development. 
Primitive populations living apart from the industrial world 
are not affected by hypertension (Philippe Meyer, 1980, p. 
11). It seems that people in these populations remain 
protected from hypertension as long as they maintain their 
primitive way of life. If they migrate toward 
industrialized regions or adopt a style of life similar to 
ours, then blood pressure increases become a concern. Also, 
along the lines of social factors, blacks are about twice as 
likely as Caucasians to develop high blood pressure (Thomas 
Wilson, 1986, p. 280). This fact may reflect an interaction 
between a modern high-salt diet and genes that adapted to a 
historical scarcity of salt. Those persons with ancestors 
who consumed little salt are at greater risk because their 
genes tend to make them less tolerant of the salt in a 
modern diet. Additionally, anyone who has an immediate 
family member wjth hypertension is at a greater risk, which 
means that hypertension does indeed have a genetic 
component. It is difficult to demonstrate exactly how 
genetic factors intervene, but hypertension is more frequent 
in persons from families with a history of raised blood 
pressure. 
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Along with social and genetic factors there are 
behavioral factors that contribute to raised blood pressure. 
A study conducted by Seppo Aro in 1984 set out to show 
correlations between various habits and blood pressure 
levels. The health-related habits he studied included: 
smoking, drinking, leisure-time physical activity, relative 
weight (fat-free weight), and change in weight over the time 
of the study (p. 334). The study was based on a sample 
drawn from employees of three metal industry plants. The 
initial sample group was followed for five (5) years to 
ensure stability of results. The study concluded that there 
is a strong and consistent association of relative weight 
with both systolic blood pressure and diastolic blood 
pressure. Cigarette smoking and frequency of mild 
intoxication were also associated particularly with systolic 
blood pressure. Weight change was the strongest predictor 
of diastolic blood pressure change 
changes and behavior modification 
(Table 
can 
1) . Lifestyle 
be used to combat 
these factors which can increase your risk of becoming 
hypertensive. A physician can make recommendations 
regarding diet, exercise, smoking cessation, and reduced 
alcohol consumption. 
Finally, psychological factors or stress can effect 
blood pressure levels. Herbert Benson, director of Beth 
Israel Hospital's Division of Behavioral Medicine and 
Hypertension Section in Boston, has done research which has 
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shown that when people are under stress, their blood 
pressure increases, their muscles tighten, their heart rate 
goes up, and their breathing quickens (Johnson, p. 170). In 
some circumstances this response is appropriate, but if 
stress is prolonged it can damage the body by 
overstimulating it, resulting in hypertension. 
In the study done by Aro, it was concluded that 
psychological stressors can have an effect on blood 
pressure; however, it has been difficult to specify exactly 
how stress works to force sustained elevation of blood 
pressure. Stress itself does not give a person high blood 
pressure, but the person's response to it can. 
Physiological cause. 
So, what is the physiological cause of high blood 
pressure? Dr. John H. Laragh, M. D., Chief of cardiology 
and director of the hypertension and cardiovascular center 
at New York Hospital, has found that a malfunction in the 
kidney's control mechanism sets off a chemical chain 
reaction which causes blood vessels to constrict. This in 
turn causes WUŸĚ body to retain more sodium, as well as 
increasing total body fluid (Johnson, p. 168). Dr. Laragh 
believes that the effect of either narrowed blood vessels 
or increased liquid is what creates hypertension. 
Treatments 
High blood pressure has no cure, but it can be 
controlled. As mentioned previously, behavior changes such 
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as maintaining a desirable weight, reducing dietary sodium, 
increasing vigorous exercise, moderating alcohol 
consumption, and smoking cessation are ways to assist in 
blood pressure control. Also, relaxation techniques can be 
practiced. However, medication is often needed to keep high 
blood pressure under control. There are three principal 
groups of antihypertensive drugs: 1.) Diuretics, 2.) 
Drugs acting on the nervous system, and 3.) Peripheral 
vasodilators (Meyer, p. 153). 
Diuretics wash out salt (sodium) from the body by 
reducing the amount of water retained in the blood vessel 
walls. They also reduce the number of nerve impulses from 
the brain and decrease adrenaline. This group of drugs is 
the most commonly used group to control hypertension. 
Drugs acting on the nervous system are called 
adrenergic-inhibiting agents. These drugs reduce the 
tension of the blood vessels by blocking the nervous or 
chemical stimuli that cause blood vessels to constrict. 
Finally, peripheral vasodilators relax the blood 
vessels so that blood flows through the arteries more 
easily. Again, the type and amount of medication taken will 
be determined after consultation with a physician. 
ECONOMICS OF HYPERTENSION 
Health promotion 
Hypertension is one of the major challenges facing 
American medicine simply because it affects a very large 
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number of people. The economics of health care, and more 
specifically hypertension, need to be studied in terms of 
the cost implications and the benefits that treatment can 
bring about. Employers are aware of the financial impact of 
rising health care costs because many of them have been 
faced with 20% to 80% increases in these costs over the past 
several years (Roger Reed, 1984, p. 41) • As a result of 
these dramatic dollar increases many companies have decided 
to attack health care costs by utilizing health promotion. 
Health promotion educates people about health risk factors, 
helps people identify their health risk factors, assists 
them in the elimination/reduction of these risks, and 
assists them in maintaining healthier lifestyles. The 
question then becomes: Is the health promotion effort worth 
it? Can corporate health promotion programs have a 
significant impact in reducing risk factors and illnesses? 
Aggregate cost figures 
There are two basic ways in which information on the 
costs of illness and the costs of medical care can be used 
to influence health care decisions. The first is to use the 
. 
aggregate cost figures to describe the magnitude or 
importance of a particular health care problem and/or 
solution. The second is cost-effectiveness analysis which 
can help in selecting between alternative approaches to 
treatment or uses of health care (William B. Stason, 1983, 
p. 250). 
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The economic costs of an illness are the costs that are 
most often brought out in the media. These costs include 
the economic costs of hypertension to society. Accurate 
estimates are hard to come by because it is difficult to 
separate high blood pressure from other risk factors, and it 
is difficult to decide how to value human life or economic 
productivity (Stason, p. 252). 
Cost-effectiveness analysis 
Cost-effectiveness analysis is backed by two 
assumptions: 1.) Health care resources are limited which 
is why costs must be contained, and 2.) Both costs and 
effectiveness may have different meanings to different 
managers. Stason has developed a multistage model for the 
management of hypertension (Figure 1). To develop this 
model he specified costs; direct and indirect. Direct 
medical care costs of treating hypertension include 
physician visits, laboratory examinations, and medications. 
Indirect costs include savings in death from strokes, etc. 
that were prevented, costs of treating medication side 
effects, and costs of health care in added years of life. 
Measures of effectiveness considered in the model 
include increased life expectancy, improved quality of life 
from morbidity prevented, and the adverse effects of 
treatment on the quality of life. Cost-effectiveness 
results are shown in terms of the net dollar cost per year 
of increased quaiity adjusted life expectancy gained. 
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Stason believes that additional expenditures for 
hypertensive care are extremely unlikely to reduce total 
health care costs. He estimates that only slightly over 20% 
of the cost of treating hypertensives (initial diastolic 
blood pressure of 105 mm Hg +) will be recovered through 
savings from reduced hospitalization for strokes and heart 
attacks (p. 258). 
How can the results from cost-effectiveness analysis be 
used by managers? Results can be used to influence 
decisions in the allocation of health care resources; within 
hypertension and between hypertension and other medical 
areas. Also, cost-effectiveness results can provide 
incentive to implement programs by showing evidence of 
positive indirect effects that can be realized through 
health care. The results by themselves will have only a 
limited impact, 
benefits should 
but increased awareness of costs versus 
achieve a lot in 
controlling health care costs. 
Studies evaluating cost-effectiveness 
The ŮŲŤȘŤŸÙŪŦĚ overview of the 
the direction of 
"Economics of 
hypertension" should provide for clearer understanding of 
the following studies that have evaluated various cost-
effectiveness measures. In 1981 Alexander G. Logan reported 
on his controlled study that was conducted to assess the 
cost-effectiveness of a work-based hypertension program in 
which all care was provided onsite (p. 211). Participants 
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(those with high blood pressure) were divided into groups 
for either treatment at the worksite (WS), or in the 
community from physicians in private practice (regular 
care, Re). Those in the WS group were evaluated at entry by 
a physician, who helped them establish a goal blood 
pressure. Hypertensive therapy was initiated and long-term 
follow-up was provided on company time. Those in the RC 
group were also evaluated at entry by a physician and then 
given an appointment with their own doctor. Screening data 
Reassessment at was sent to patients' respective doctors. 
work was done 6-12 months after program entry. 
Costs were assessed for each group and were reported as 
the average cost per patient. Costs taken into account 
included medical care costs for the organization and the 
patient, screening costs, and treatment costs. The 
effectiveness measure was the average reduction in diastolic 
blood pressure over one year. Therefore, cost-effectiveness 
was calculated as the ratio of the average cost per patient 
to the average reduction in diastolic blood pressure over 
one year. Logan. found that the WS program was more costly 
by $31.52 per patient per year, but that it was able to 
achieve an additional reduction in diastolic blood pressure 
of 5.6 mm Hg. This study showed that treatment of employed 
hypertensives at their work-place is both more effective and 
more cost-effective than usual care in the community (p. 
216). The major cost saving of the WS program was the 
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reduction in patient cost. The work setting facilitates 
access to care, targets a population where the consequences 
of hypertension are large, and encourages longer-term 
follow-up. Logan 
control programs 
concluded that effective hypertension 
have great potential for improving 
productivity and/or reducing costs associated with 
absenteeism or premature death. 
In 1983 Logan conducted another study to assess the 
clinical effectiveness and cost-effectiveness of monitoring 
blood pressure of hypertensives at work. In this study 
there were again two groups 
where hypertensives saw their 
occupational health nurse (OHN) 
a regular care (RC) group 
family doctors only, and an 
group where employees were 
treated by their family doctor plus the nurse (p. 829). The 
cost-effectiveness of the treatment programs was again 
calculated as the ratio 
the average reduction in 
of the average cost per patient to 
diastolic blood pressure over one 
year. The occupational health nurse made sure that 
employees saw their family physician. The nurse also 
scheduled regular visits with employees in the OHN group to 
measure blood pressures, to question compliance, and to 
communicate results to the family physician. 
The results of this study indicate that "monitoring the 
blood pressure of hypertensive employees at work is neither 
clinically effective nor cost-effective" (p. 835) • The 
increased cost of treatment brought about by hiring and 
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utilizing the OHN were greater than the improvement of blood 
pressure reduction. However, it was determined that the 
treatment dropout rate in the OHN group was 5.5% lower than 
the RC group. This suggests that monitoring does at least 
influence hypertensives, despite the fact that the increased 
cost of treatment made this method less attractive. 
Logan's two studies have shown that analyzing the costs 
and benefits of various hypertension control programs is a 
very complex process. 
variables in their 
Managers have to carefully assess the 
own 
decisions about any type 
corporate situation before making 
of health care program. It does 
appear that worksite hypertension control programs ŸĚbe 
cost-effective; however, excess intervention can be costly. 
In 1984, John C. Erfurt and Andrea Foote conducted a 
cost-effectiveness study of hypertension programs in four 
automobile manufacturing plants. Each plant had a different 
approach to follow-up. Screening procedures were the same 
at the four sites. At site #1 no follow-up was conducted 
except for a courtesy letter sent to the employee's 
physicians (control site). At site #2 modified follow-up 
was initiated, with a blood pressure counselor contacting 
each hypertensive employee every 6 months. At site #3 full 
follow-up was initiated, with contact every 6 months as well 
as routine contact with employees' attending physicians. At 
site #4 an on-site treatment program was implemented with 
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educational efforts put into place. To assess costs, 
detailed daily time records were kept by all project staff. 
The largest cost was for the follow-up/monitoring 
activities, with administrative costs also an important 
consideration. The measure of effectiveness was defined as 
the adequacy of blood pressure control at the end of the 
study. It was found that the cost of intervention was 
lowest at site #2, at $26.26 per hypertensive employee per 
year, and highest at site #4, at $96.19. Site #1 did not 
have any intervention costs since there was no intervention. 
It was used only as a basis for comparison. In computing 
the effectiveness the data show there were large and 
significant improvements in the number of people who had 
their blood pressure under control at the end of the study, 
I 
with the largest improvement at site #4. Across the three 
follow-up interventions, each dollar spent on the program 
per client resulted in an additional 1% of the hypertensive 
group being maintained under control (p. 897). This is the 
reverse of the cost-effectiveness ratio which produces the 
annual dollar ȘŬŸWĚper unit of effectiveness. Erfurt and 
Foote were able to show that work-site blood pressure 
control programs can be cost-effective, but that 
effectiveness can vary considerably, depending on the 
additional costs a company might incur as a result of 
adopting a hypertension control program. 
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Additional considerations 
Any analysis will vary depending on how costs are 
measured. Costs must always be specified as costs to whom, 
since every cost to one party can be a benefit to another. 
In the previous studies mentioned, the costs were incurred 
by the organizations who adopted a hypertension control 
program for their employees. Treatment costs to the 
employees such as physician visits, laboratory tests, and 
medications were not computed. 
Before making the decision to implement a blood 
pressure control program a company must look at many factors 
rather than just the cost-effectiveness ratio. If it can be 
demonstrated that savings in employee retirement/replacement 
costs, short- and long- term disability payments, and health 
care coverage premiums can be realized, then a work-site 
program would probably be feasible. 
On the other hand, a firm's current benefit package 
might already provide coverage for various aspects of 
hypertension intervention (off-site care, prescriptions, 
etc). In this case a manager must evaluate the current 
policies and/or programs to determine if it would be wise to 
implement an on-site program. Further consideration of 
economic factors as well as the feasibility of specific 
programs should be well thought out before action is taken. 
The selection of a hypertension control program depends 
on cost considerations; however, a minimal level of 
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effectiveness is usually expected. If an intervention 
program does not produce an adequate level of effectiveness, 
then a company might decide that the additional cost 
necessary to achieve a particular level of effectiveness is 
worth it (to the organization). For example, if rewards 
such as increased employee satisfaction, improved employee 
productivity, and decreased absenteeism can be seen through 
the implementation of a more extensive program it may be 
worth the extra expenditure to implement a work-site 
program. However, one must remember that the most common 
constraint on health intervention and/or education programs 
is budget. If the money is not available then other 
alternatives must be considered. 
Educational intervention 
Up to this point actual work-site programs have been 
discussed in detail. Another strategy in dealing with blood 
pressure control involves educational intervention. In a 
study conducted by Joel C. Cantor in 1985, combinations of 
educational interventions were evaluated to (again) 
determine ȘŬVWĤŸȚȚŤȘWÙẂŤŪŤVVĦĚ The three phases of the 
educational program used in this study included: 1.) a 5-
to 10- minute interview with the patient immediately 
following the medical visit to clarify problems or other 
questions, 2.) an educational session in the home with an 
adult with whom the patient has the most contact, and 3.) a 
series of three, 1-hour group discussions centered on 
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hypertension management and compliance (p. 783). Costs in 
this study measured program costs and social costs to the 
patient. Measures of effectiveness evaluated behavioral 
risk factors, ie. medication-taking behavior, appointment-
keeping behavior, and weight loss, as well as actual blood 
pressure readings. Study groups were divided so that some 
persons were getting one phase of education while others 
were getting combinations of two or three phases. Cantor 
found that the multiple interventions showed high 
effectiveness on most outcomes, but were costly. Modified 
educational efforts were more cost-effective, and more 
easily integrated into currently existing health programs. 
Single interventions, especially the home visit, can be very 
effective in improving blood pressure control. 
The amount of educational intervention depends upon 
what a particular company is trying to accomplish. Again, 
budgets may be limited, blood pressure control objectives 
may vary, and organizational needs may change over time. A 
manager must remember that follow-up is the most expensive 
component of a tptal intervention/educational program; about 
5/6 of the program involves follow-up expenses rather than 
screening expenses (Erfurt and Foote, 1977, p. 340). 
However, during subsequent years of follow-up, patients will 
require less time and expense on the part of a company. It 
is up to various company managers to assess where their 
organization stands in terms of blood pressure control, and 
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what they want to achieve in the future. When goals are 
established, company decision-makers can proceed to 
implement programs and changes. 
Yield from risk reduction 
Another way of approaching blood pressure control 
programs from a busineess standpoint is by looking at the 
ŸXÙŤŨTŸĚ of such a program. In terms of health, the yield 
from such efforts is the "extent to which risk in the entire 
work force is lowered" (Laura C. Leviton, 1987, p. 931). 
Other benefits such as increased morale, enhanced company 
image, and increased productivity can be realized, but the 
yield for health is an important justification for a 
company-wide intervention. Only a few workplace studies are 
well controlled. These studies do not always represent the 
entire range of work settings, populations, and outcomes; 
therefore, in the study involving the yield from workplace 
interventions all available reports are presented. 
Leviton defines the outcomes in workplace studies as 
being participation, retention, and indicators of risk 
reduction. Participation rate is the proportion of the 
known at-risk group that is actively involved at the 
beginning of an intervention (P) • Retention rate is the 
proportion of participants still involved at the end of an 
intervention (R). An 
retained participants 
variables can then be 
indicator of 
brought under 
multiplied (P 
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risk is the portion of 
control ( I) . These 
x R x I) to calculate 
the yield from a workplace program. Gross yield is the 
proportion of the work force who reduced risk, without 
considering what would have happened with no intervention. 
This figure is important when a manager is looking at the 
raw data collected from a study. The gross yield can show 
the need for intervention when it is evident that there is a 
high number of at-risk employees. Net yield reflects what 
would occurred in the absence of intervention. In other 
words, the net yield is the gross yield in the intervention 
group, minus gross yield in the control group (p. 932). 
It seems that participation and retention rates in 
hypertension control are the UÙŦŸŤVWĚ of any workplace 
activity, including smoking cessation, cholesterol 
screening, etc. (Table 2). With all the attention given to 
hypertension over the past decade, one would think that the 
United States population had gotten the problem under 
control. However, as of 1988, the United States Public 
Health Service has found that only 11% to 24% of those who 
are hypertensive have their blood pressure under control 
(Carla L. Barnes 4 1988, p. 113). This figure conflicts with 
the 41.2% figure that Leviton reported in 1987. Despite the 
fact that public awareness about hypertension is high, there 
are still thousands of people who are untreated or treated 
unsuccessfully. At each step of the process, from detection 
through long-term follow-up, large numbers of patients fall 
out of care. According to R. Brian Haynes, up to 50% fail 
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to follow through with referral advice, over 50% of those 
who begin treatment drop out within 1 year, and only about 
two-thirds of those who stay under care consume enough of 
their prescribed medication to achieve adequate blood 
pressure reduction (1982, p. 415). 
COMPLIANCE 
Problem 
Low compliance has been and still is a major problem 
facing individuals with high blood pressure as well as 
employers and society in general. Compliance is the extent 
to which a person's behavior coincides with medical advice. 
The "health belief model" is the most common motivational 
model of compliance. 
It says that an individual's 
cooperation with health advice depends upon the extent to 
which that person perceives that he/she is susceptible to 
the disease, that the disease is serious, that treatment is 
beneficial, and that the barriers to compliance are possible 
to overcome (Haynes, p. 416). 
After a person has come to the conclusion that barriers 
. 
are possible to overcome, it becomes easier to enforce the 
importance of sticking with treatment. To efficiently 
manage patient compliance, accurate methods of measurement 
must be administered. 
Monitoring attendance at appointments is critical 
because this is one of the first steps in developing 
awareness about hypertension. Along with this, patient 
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self-reports are a valuable way of obtaining information 
directly from the patient. The patient can determine 
his/her pattern of medication consumption from monitoring 
himself. Pill counts can also provide an accurate estimate 
of compliance over time. 
Dealing with low compliance 
In order to maximize an employee's compliance it is 
essential that his/her blood pressure be checked regularly, 
that oral and written feedback be provided about blood 
pressure levels, that the prescribed regimen be discussed, 
and that questions be encouraged and answered (Barnes, p. 
114). Once the patient is under care for hypertension, 
additional efforts are usually required to maintain control. 
The most successful interventions for improving compliance 
are characterized by interactions between providers and 
patients. This leads to the conclusion that the level of 
supervision of and attention to ongoing care is a key 
factor. 
patient 
pressure, 
decrease 
Options for interaction include 
for improved compliance and/or 
tailoring of medications to daily 
forgetting and inconvenience, 
rewarding the 
lowered blood 
schedules to 
support, encouraging self-help 
discussion, and negotiating 
through 
encouraging family 
group support and 
a brief written contract with 
the patient for improvements in health behavior (Haynes, p. 
419) . Of course, screening programs must be supported and 
medication must be taken as prescribed to achieve optimal 
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control. In addition, previous studies have shown that 
regularly scheduled follow-up 
hypertension control. 
is also essential for 
Once a person is thinking along the lines of longer-
term control, the easier it will be to stick with a 
prescribed treatment program. 
in determining if a control 
otherwise) is successful. 
Compliance is the sole factor 
program (work site based or 
A program might look good on 
paper, ie. conduct regular screenings, offer educational 
intervention, and even follow-up programs, but if compliance 
remains low then the overall problem has not been solved. 
CONCLUSION 
Goals 
The advancements made over the past decade regarding 
awareness and education about hypertension have been 
impressive. In a 1985 national public awareness survey, 92% 
of the adult population were aware that high blood pressure 
increases one's chances of having heart disease, and 73% of 
the population had had their blood pressure checked within 
the past year (Barnes, p. 113). However, the United States 
Public Health Service goal of getting 60% of the population 
under successful long-term blood pressure control, is 
unlikely to be met. 
The fact that so many people still do not have their 
blood pressure under control is cause for concern for health 
educators, employers, and society in general. 
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Businesses 
have found that cost savings can be realized if their work 
force is healthy and keeps risk factors under control. This 
is a primary reason for the concern of managers over their 
employee's lifestyles. 
Future considerations 
For the future it will be necessary for managers to 
emphasize the importance of the benefits of healthy living. 
Businesses will benefit by gaining a more competitive work 
force, and individuals will benefit from the improvements 
that will be seen in themselves. However, for the near 
future, most workplace efforts will be fairly low budget and 
will not have access to either the facilities or the 
expertise that the "model" programs take advantage of 
(Leviton, p. 931). 
Because hypertension is the most prevalent of all 
cardiovascular diseases, it deserves the attention of all 
individuals. Through continued education and follow-up 
programs, progress toward obtaining improved compliance 
rates should be realized. 
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STRESS. BEHAVIOR. AND BLOOD PRESSURE 
TABLE 1 
AGE-ADJUSTED PAmAL COIII1.AT10N' (r) I!TWEEN PREDICTOI VAIIAIILES AMD BLOOD PRESSulE 
tBP) V","UIS AT THI BEGINNING 0' THE FOLLOw·UP " .. 0 ŠŸNÓĚPREDICTOR VAIIAILES AND BP 
CHANGE (II • 3881 
Predictor S8P DBP 
Yariabfe in 197] in 191] S8P chan ... DBPchan __ 
(ia (913) (" (" t" 
." 
.. lad .. weicbt 0.16 O.ll -0.02 0.'" 
Weicht cJIance 0.11 0.26 
lacoxicaIioa 0.11 0.09 0.04 0.1" 
Cipretta per day 0.1" 0.01 0.01 0.10 
PIIysicaI actmly 0.10 0.04 0.00 0.0' 
• IP in 1971 _us 8' ia 1973. 
r a 0.10. P < O.M. 
, a 0.13. P < 0.01. 
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, -It. 
5. 5,; S.; Sp· S • 
.. , 
tip 
T.Jfge' SusMc*I T....-. ContnMIeG 
ŸĤ ...,..n-- -... conttnu.o 
t - .. t _-, 
Frprr I. Multistage model (or the management ofhypenc:nsion 
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TABLE 2 
VieICI '""" INcrtt Site FIIISIC FII.auc:nan ŸĚ
11' ........ - s-trII) OlDt .... au- c....- o.-_ HHŸĚ
PartJQOaQOn Rate" 
MecMn I*'I*'t (al studieS. 75.2 ŸĦİĚ ŸĚ
IV 'al S1UOeS' 20 22 4 ŸĚpen:ent (pUCIisMd)§ 75.4 66.5 50 
N (puc!iSheG' 19 12 3 
Range I*'I*'t (al ssum-J't 37-91 1-. 22.8-G 
A.-lDan,.. 
MecMn I*'I*'t (II ..... 93 91 12.2 
N( ........ 15 15 2 
ŸĚŸWĚ(pubIisneG) 93 94.5 12.2 
N (puCIIiSned) 15 10 2 
R.-.gel*'l*'t (II ssum-. 77-100 17-100 79.3-85 
ImOI O¥eI!'*It iI iCIiC:atOr: 
Mecan pen:81t tal studIIIS, 68 32 9.5 
ÔĜŠŅŸGĚ 23 s.a 10 
".." cerc:ent (guI)IiSI'IeC) 68 25 7.8 
ÔĜŸĞĚ 22 23 8 
Range percent (all studIeS, 23-a9 9-100 0-16.2 
Gress yIIIId 
Median pen:ent (all studieS, 41.2 16.1 -, 
N tal StuaMlS' 12 11 
Mecan percent (puCIiSnea) 41.2 18.2 
N (pucllisneal 12 9 
Range percent (all studieS) 20.1-01.4 1.4-26.6 
• Ooes not conSlQef' saeen'"9 parncoaQOn (see text,. 
t Ranges are vtrtuaIIy me same far pucIISned st1JdIe5 and far total 
stuaJes. 
: lmorovement InalC3tCB went defined as percent 'NI1t'i 0I00d cres-
sure 1 40/90 or oetOW. percent QUItting smokll"9. >If mean percent 
reduction .n d1OIeSterOI. 
§ PuDIIsNa ouu:omes .ncIude orWy tnoIIe 1ft ŸĤŪÓŤPŤTĚjowna&L 
Two stuCeS.ncauaecs grass ana,. yieIC 0I'IIf. 
'See text. 
. 
*Participation rate in the 
hypertension control group 
is 75.2%, implying that programs 
for high blood pressure are 
widely taken advantage of. 
*Retention rate in the hypertension 
control group is 93%, implying 
that most employees actively 
participate in hypertension 
control programs. 
*Improvement was realized bv 
68% of the emplovees in the 
hypertension control group. 
**Twelve (12) studies supplied the above outcomes. 
--The gross yield of known hypertensive persons in a 
work force whose blood pressure is under control 
is 41.2%. This figure is derived by calculating 
participation, retention, and indicator of risk. 
--The hypertension control group has had better success than 
smoking cessation or cholesterol reduction programs. 
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Activity Summary-Blue Cross Blue Shield 
Spring 1988 
Part B 
I have spent the quarter doing research on hypertension for 
my thesis paper, as well as learning about various other aspects 
of Wellness while working with Blue Cross Blue Shield in Indian-
apolis. Cathy Nordholm, Hypertension Coordinator in the Blue 
Cross Blue Shield Wellness Resource Center, has been my guide and 
has provided me with several contacts in the Wellness area. I 
have had the opportunity to meet with a variety of people and I 
have learned a lot about health related issues and the impli-
cations they have for business. 
The Wellness Resource Center at Blue Cross Blue Shield 
provides information and training to businesses through several 
methods/programs. These include Stay Alive and Well, Your 
Healthy Best, worksite based high blood pressure control, 
wellness payroll stuffers, and health booklets. 
Stay Alive and Well is a cost-effective program that helps a 
company manage health care costs. The program begins with a 
personal health survey followed by a mini-exam (physical). 
Results are then reviewed with the person and the information is 
analyzed. Finally, employees are assigned to various inter-
vention groups to modify their behavior, and follow-up then 
takes place. 
Your Healthy Best is a self-help program where employees are 
taught positive motivation techniques and how to set personal 
goals for change. This program is flexible and uses any number 
of mediums including a video, guide book, personal fitness diary, 
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self-help handbook, newsletter, and lifestyle assessment pro-
files. An employee can do as much or as little as he/she would 
like toward making positive changes in his/her lifestyle. 
The worksite based high blood pressure control program is 
set up to help employees of a company gain and maintain blood 
pressure control. The program includes informing all employees 
about high blood pressure, screening employees to detect possible 
causes of high blood pressure, referring all employees with high 
blood pressure readings to their physicians, and long-term 
monitoring of diagnosed hypertensives at the worksite. 
Wellness payroll stuffers are used to educate employees 
about the use of health care services. The stuffers are an 
inexpensive way for an employer to provide positive health tips 
and information on taking better care of one's self. 
Finally, health booklets are available on vital health 
issues. Books available include: Feel Better, Food & Fitness, 
Stress, and the Self-Help Handbook of Symptoms and Treatments. 
These programs offer a variety of methods to educate a 
company's employees about the importance of wellness. The people 
in the Resource Center are knowledgeable about the wellness area 
and how wellness relates to the "business aspects" of running a 
company in terms of cost savings, etc. 
realized from Wellness education at 
employees and at the company level in 
cents. 
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There are benefits to be 
a personal level for-
the form of dollars and 
The following information is a summary of my activities 
throughout the quarter. I travelled to Indianapolis this Spring 
and spent Tuesday afternoons and Wednesday at the Wellness 
Center. I was able to meet with several people and learn about 
their jobs as well as participate in other activities pertaining 
to my areas of interest. 
3/15-16 Met with Phyllis Mendenhall, Senior Personnel Special-
ist at Blue Cross Blue Shield. Ms. Mendenhall talked about her 
job in personnel, and passed along some valuable insight as to 
what a job in human resources involves. She informed me about 
how the personnel function at Blue Cross Blue Shield is organized 
and how the various other Blue Cross offices fit into the scheme 
of things. 
We talked about recruitment, compensation, training, and the 
Blue Cross Blue Shield Human Resource Information Center. The 
purpose of this contact was for me to learn more about what a 
human resource manager actually does on-the-job. I understood 
the various "personnel terms" that Ms. Mendenhall used, such as 
exempt vs. non-exempt employees, corporate salary surveys, and 
job analysis by way ot the point method. The information I 
gained was helpful and I was glad to have the opportunity to talk 
with someone in this type of position. 
3/15-16 ŸŤWĚwith Jan Ranger of Key Health Plan (subsidiary of 
Blue Cross Blue Shield). Jan is a Wellness Specialist and works 
with various companies in a consulting capacity. She gives 
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presentations in the areas of CPR, smoking cessation, stress 
management, weight control, and high blood pressure education. 
My meeting with Jan was very informative. She explained the 
differences between the various types of HMO's, and then pro-
ceeded to talk about the types of presentations and other work 
she does. This meeting provided me with a better understanding 
of how a "manager" functions in the wellness area, and it left me 
feeling optimistic that there are job opportunities in a business 
setting for persons interested in wellness. 
4/12-13 I listened to Wayne Hedden, President of Valhalla 
Scientific, give a sales presentation on a body composition 
analysis system. This was basically a computer that hooks up to 
a person's body by way of electrodes and then determines one's 
percent body fat, total body water, target weight range, etc. 
The presentation was interesting because I had never seen a piece 
of equipment such as the one he demonstrated. I was also able to 
observe an actual sales pitch which made me take a look at the 
technique, style, and approach that were used. 
4/19-20 I attended a conference of the Indiana Association of 
Health Educators. The Association held their spring meeting, as 
well as having a dinner and 
with networking and I was 
health related fields. The 
speaker. The evening started out 
able to meet several new people in 
speaker, Dr. Roger Pinto of the 
Indiana Heart Institute, had a varied background: his bachelor's 
degree in Personnel Management, his master's degree in Exercise 
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Physiology, and his doctorate in Psychology. Dr. Pinto spoke on 
"Helping Behavior Changes Stick: The Prevention and Treatment of 
Relapse". He focused on correcting undesirable behaviors 
(alcoholism, overweight, smoking), and then on how to maintain 
the new, healthy habits. He tied everything together by empha-
sizing the gains to be realized by the individual (and also 
acquaintances and employers), if he/she took control and actively 
pursued a healthy lifestyle. 
I attended a lecture given by Jane Brody, Health and 
Brody spoke about the Nutrition expert - New York Times. 
benefits of healthy living. She 
Ms. 
specifically addressed the 
hazards of smoking, the importance of good nutrition, and the 
positive effects of a regular exercise program. The lecture 
reinforced my commitment to healthy living and was inspirational. 
My only concern was that people are often motivated after hearing 
a lecture such as this one, but do not carry through with 
implementing long-term changes. It's easy to talk about these 
health issues but permanent changes are often difficult to make. 
ŸĚ I attended a presentation given by Janet ZeBell, 
Wellness Consultant-Blue Cross Blue Shield, at the Henry County 
Memorial Hospital. Janet was promoting the Stay Alive and Well 
program, which is one of the benefits provided to hospitals who 
are members of the Preferred Care network. She talked briefly 
about the purpose of her visit; which was to inform and elicit 
interest in this particular wellness program. There was a brief 
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slide presentation, and then Janet went through the contents of 
the packets she had brought along. 
In this presentation there was no pressure put on the 
hospital administrators since the program is available to them at 
no charge. The hospital only has to purchase the materials from 
the Resource Center, while the training, etc. is done free of 
charge. So what does Blue Cross Blue Shield get out of ŸŦÙẂÙŪŦĒĚ
this wellness program to members of the pcr system? They benefit 
from the networks that are created once a hospital gets involved 
with the program. The hospitals are free to market and promote 
the Stay Alive and Well material as it suits their needs or 
particular situations. 
I learned a lot from observing this exchange. Janet was 
very poised and convincing, and I felt she came across as being 
credible. I sensed that Blake and Elaine (of the hospital) were 
receptive toward the program, but were being realistic in their 
thinking that changes take a good amount of time to be success-
fully implemented. r realize the importance of the whole 
wellness concept, but I know that seeing actual results and 
evidence backing the. concept are the keys to making a program 
work. 
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Conclusion 
These meetings and activities have given me exposure to 
expert views on Wellness and Personnel related issues. I have 
earned a lot about various positions, and I realize that there 
are many career paths that I 'could choose with my background. 
The practical experience I have gained should prove to be a 
valuable asset when I start my own career and find myself in a 
decision-making role. 
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